4//SEC Filing
Dahlquist Karl S. 4
Accession 0001323885-24-000040
CIK 0001323885other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 7:28 AM ET
Size
5.1 KB
Accession
0001323885-24-000040
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Dahlquist Karl S.
Chief Legal Officer
Transactions
- Sale
Common Stock
2024-03-05$37.36/sh−8,231$307,510→ 52,839 total
Footnotes (2)
- [F1]These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $36.57 to $37.74 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
AtriCure, Inc.
CIK 0001323885
Entity typeother
Related Parties
1- filerCIK 0001861996
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 7:28 AM ET
- Size
- 5.1 KB